Healthcare

New investors in healthcare startup LillianCare’s funding round included German impact investor BONVENTURE and Spanish impact investors Creas.

The fund will invest in early-stage healthtech startups. It plans to bring scale through its partnerships with a variety of different health organisations around the world.

The European Investment Bank and the European Commission have joined forces with immunotherapy company BioNTech to advance a mRNA vaccine manufacturing facility in Rwanda.

Aerska develops RNA medicines for the treatment of neurological diseases such as Parkinson’s and Alzheimer’s, which affect millions of people worldwide.

The funding will enable the company to scale and commercialise its cloud-linked device, which allows medical professionals to remotely monitor key patient indicators such as heart rate, respiratory rate, and oxygen saturation.

Genoskin has developed a tool that can test pharmaceutical, cosmetic and chemical products on real human skin, offering an alternative to animal testing.  

Carrots as well as sticks are required to generate more private sector interest in social impact, according to the Schwab Foundation’s Daniel Nowack.

The impact investor’s recently launched inclusive growth strategy focuses on businesses that are delivering positive outcomes for vulnerable people in the UK.

Ultromics raised the financing in a Series C funding round, led by Lightrock, L&G, and Allegis Capital, for the expansion of its AI-powered diagnostic echocardiogram technology, which was developed in partnership with the UK NHS and Mayo Clinic.

The African healthcare firm has grown into a chain serving two million customers a year. LeapFrog has sold its remaining stake to CFAO Healthcare.